Evidence map›Paper›PMID 26997918›Full record

ArticleFuture neurology2015

The future of stem cell therapy for stroke rehabilitation.

Cesar V Borlongan, Jukka Jolkkonen, Olivier Detante

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. An update on stem cell therapy for stroke patients: Where are we now?Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Review
  2. Review
  3. Review
  4. Endovascular Ischemic Stroke Models in Nonhuman Primates.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2018
    Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Cesar V BorlonganDepartment of Neurosurgery and Brain Repair, Morsani College of Medicine, University of South Florida, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.
Jukka JolkkonenUniversity of Eastern Finland, Institute of Clinical Medicine - Neurology, Yliopistonranta 1 C, 70210 Kuopio, Finland.
Olivier DetanteUniversity Hospital of Grenoble, Stroke Unit, Department of Neurology, CS 10217, 38043 Grenoble, France; Inserm, U 836, BP 170, 38042 Grenoble, France; University Grenoble Alpes, Grenoble Institute of Neurosciences, BP 170, 38042 Grenoble, France.
Inserm · FRUniversity of Eastern Finland · FIUniversity of South Florida · US

Funding

Blood-Brain Barrier Repair in Cell Therapy for StrokeR01NS071956 · NINDS · UNIVERSITY OF SOUTH FLORIDA · PI BORLONGAN, CESARIO V, GARBUZOVA-DAVIS, SVITLANA NICOLAI · 2011 to 2015
$2.1M
NINDS NIH HHS R01 NS071956
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cell transplantationcerebral ischemiaexercisefunctional recoveryneural progenitorsphysical activitytranslational research

Identifiers

PMID26997918
PMCPMC4795912
OpenAlexW1913888724

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.